
Vetoquinol SA
PAR:VETO

Vetoquinol SA
Revenue
Vetoquinol SA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Vetoquinol SA
PAR:VETO
|
Revenue
€537.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
![]() |
Sanofi SA
PAR:SAN
|
Revenue
€44.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
![]() |
Ipsen SA
PAR:IPN
|
Revenue
€3.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
![]() |
Virbac SA
PAR:VIRP
|
Revenue
€1.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
![]() |
Boiron SA
PAR:BOI
|
Revenue
€481.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
![]() |
Medincell SA
PAR:MEDCL
|
Revenue
€10.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
Vetoquinol SA
Glance View
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.

See Also
What is Vetoquinol SA's Revenue?
Revenue
537.5m
EUR
Based on the financial report for Jun 30, 2024, Vetoquinol SA's Revenue amounts to 537.5m EUR.
What is Vetoquinol SA's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Vetoquinol SA have been 3% over the past three years , 8% over the past five years , and 6% over the past ten years .